Federal Trade Commission

Federal Trade Commission

  • AIPLA Comments to Federal Trade Commission on Proposed Rulemaking Regarding Consumers “Right to Repair”

    February 5, 2024

    Arlington, VA. February 1, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments to the Federal Trade Commission (FTC) in response to the petition for rulemaking to protect consumers’ right to repair products they have purchased.
  • AIPLA Comments on Federal Trade Commission Non-Compete Clause

    April 21, 2023

    Arlington, VA. April 21, 2023 - The American Intellectual Property Law Association (AIPLA) submitted comments to the Federal Trade Commission in response to their published notice on Non-Compete Clause Rulemaking, 88 FR 3482, on January 19, 2023. The proposed rule would effectively ban the use of non-competes, with few exceptions.
  • U.S. Court of Appeals for the Second Circuit Vacates Final Order of the Federal Trade Commission in 1-800 Contacts Case

    June 11, 2021

    On June 11, 2021, the United States Court of Appeals for the Second Circuit vacated a Final Order of the Federal Trade Commission (FTC), finding that 1-800 Contact’s “typical trademark settlement agreements” did not unreasonably restrain trade in violation the Section 5 of the FTC Act given the lack of direct evidence of an anticompetitive effect and the strong procompetitive justification of protecting 1-800 Contract’s trademarks. The Court of Appeals also found that it did not have sufficient experience with the type of conduct at issue to permit the abbreviated antitrust analysis favored by the Commission, applying a full-blown rule of reason analysis instead. The Court remanded the case to the Commission with instructions to dismiss it.

Recent Advocacy

  • AIPLA Comments on CNIPA Draft Measures for Prioritized Patent Examination

    April 1, 2026

    Arlington, VA. March 30, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the China National Intellectual Property Administration (CNIPA) regarding the Draft Measures for the Administration of Prioritized Examination of Patents.
  • AIPLA Files Amicus Brief in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc

    March 31, 2026

    Arlington, VA. March 27, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus curiae brief with the Supreme Court in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889. AIPLA urges the Court to affirm the Federal Circuit’s application of the established Iqbal/Twombly pleading standard and inducement law in reviewing Hikma’s motion to dismiss Amarin’s claim that Hikma’s conduct, in combination with its “skinny label,” induced infringement of Amarin’s patented treatment methods.
  • Supreme Court Issues Unanimous Decision in Cox Communications, Inc. v. Sony Music Entertainment

    March 25, 2026

    On March 25, 2026, the Supreme Court issued a unanimous decision in Cox Communications, Inc. v. Sony Music Entertainment. The majority opinion limits contributory liability to situations where a party intended that its service be used for infringement, either by affirmatively inducing infringement or by selling a service tailored to infringement. A concurring opinion by Justice Sotomayor argues that the material contribution test should be retained, and that other forms of secondary liability can be found, which is consistent with the position asserted by AIPLA in its amicus brief filed on September 5, 2025. To read the opinion of the Court, please click here.
  • AIPLA Comments on the Draft Trademark Law of the People’s Republic of China

    March 23, 2026

    Arlington, VA. February 9, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the Legislative Affairs Commission of the Standing Committee of the National People’s Congress regarding the latest Draft Trademark Law of the People’s Republic of China. AIPLA recognized the NPC’s efforts to streamline trademark procedures, strengthen protection, and address abusive and bad-faith filing practices.